Development of a unique anti-AML immune therapy consisting of cord blood HSCT and cord blood stem cell-derived dendritic cell (CB-DC) vaccination

類似資料

• Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation
  著者:: de Haar, Colin, 等
  出版事項: (2015)
• Clinical Grade Production of Wilms’ Tumor-1 Loaded Cord Blood-Derived Dendritic Cells to Prevent Relapse in Pediatric AML After Cord Blood Transplantation
  著者:: Plantinga, Maud, 等
  出版事項: (2020)
• Antitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentation
  著者:: Spel, Lotte, 等
  出版事項: (2013)
• Dendritic Cell Therapy in an Allogeneic-Hematopoietic Cell Transplantation Setting: An Effective Strategy toward Better Disease Control?
  著者:: Plantinga, Maud, 等
  出版事項: (2014)
• Cord-Blood-Stem-Cell-Derived Conventional Dendritic Cells Specifically Originate from CD115-Expressing Precursors
  著者:: Plantinga, Maud, 等
  出版事項: (2019)